MICHAEL H. LOWENSTEIN, M.D. CERTIFIED BY NEW ADDICTION MEDICINE BOARD
American
Board of Addiction Medicine to Address Significant, Unmet Need
Chevy Chase, Maryland - (July 16,
2009), 2009 - Michael H. Lowenstein, M.D. is among the first physicians in the
United States certified by the American Board of Addiction Medicine, a new
independent medical specialty board. The American Board of Addiction Medicine (ABAM) has begun to certify addiction medicine physicians from several
specialties, including emergency
medicine, family medicine, internal medicine, obstetrics and gynecology,
pediatrics, preventive medicine, psychiatry, neurology and surgery. There was
previously only addiction-related board certification for psychiatrists. ABAM sets
standards for physician education, assesses physicians' knowledge, and requires
and tracks life-long continuing education.
"We want addiction
prevention, screening, intervention and treatment to become routine aspects of
medical care, available virtually any place health care is provided," said Kevin
B. Kunz, MD, President of the American Board of Addiction Medicine.
Although one in five Americans entering the health care system has a substance abuse problem,
there has never been a medical specialty board, drawn from all areas of
medicine, dedicated to certifying addiction specialists. Now, patients have a way to find specialized
medical care for substance use disorders related to alcohol, tobacco and other
addicting drugs, including some prescription medications.
"Physicians
are often at a loss for what to do about substance use and addiction issues,
and may even misdiagnose the problem," said Kevin B. Kunz, MD, President of the
American Board of Addiction Medicine. "We
hope to change this by creating a cadre of thousands of specialized physicians
across medical specialties."
Studies
show that fewer than one in five physicians consider themselves adequately
prepared to diagnose alcoholism or other drug use disorders. Physician training is sorely lacking.
Separate courses in addiction medicine are rarely taught in medical school, and
there are no addiction medicine residencies among the 8,200 American Council
for Graduate Medical Education (ACGME) accredited residency programs in the
nation's hospitals.
Dr. Michael H. Lowenstein, Certified by
American Board of Addiction Medicine
"The
American Board of Addiction Medicine will provide assurance to the American
public that Addiction Medicine physicians have the knowledge and skills to
prevent, recognize and treat addiction," said Dr. Kunz. "ABAM-certified physicians will also be able
to address common medical or psychiatric conditions related to the use of
addictive substances."
Created in
2007, with the assistance and encouragement of the American Society of
Addiction Medicine, ABAM offers a rigorous certifying examination that was
developed by an expert panel and the National Board of Medical Examiners, as
well as a re-certification examination to ensure that ABAM-certified physicians
maintain life-long competence in addiction medicine. ABAM has formed a governing body of 15
distinguished physicians from across a range of medical specialties, each of
whom is certified by a member board of the American Board of Medical
Specialties (ABMS).
ABAM is in the process of seeking recognition
from ABMS, and plans to certify physicians in multiple specialties. ABAM is also taking steps to create addiction
medicine training programs affiliated with the nation's top medical schools, and
will apply to the ACGME to accredit these programs.
The new
medical specialty board is being launched at a time of increasing promise for
addiction treatment. Recent discoveries
have added to the preponderance of evidence that addiction is a chronic disease
of the brain, with unique vulnerabilities and pathology, and a predictable
course if not interrupted by effective treatment. An increasing number of medically based addiction
treatments have become available, and more are on the horizon.
"Years of scientific research have proven drug addiction is a brain disease caused by biological, environmental and developmental factors-a disease which can have far reaching medical consequences. Given the proper training, tools, and resources, physicians can be the first line of defense against substance abuse and addiction--identifying drug use early, preventing its escalation to abuse and addiction, and referring patients in need to treatment," said Nora D. Volkow, MD, Director of the National Institute on Drug Abuse.
Congress
recently passed legislation that addresses insurance discrimination against
those with addictions, requiring as of October 2009 that private insurance
coverage of addiction treatment, when provided, is offered in the same way that
all other medical and surgical coverage is provided.
"Now that
this barrier has been reduced, we want to make sure that evidence-based addiction
treatment is available to all who need it," said Dr. Kunz.
Michael H. Lowenstein, M.D.
A graduate of the Loma Linda
University School of Medicine, Dr. Lowenstein possesses the knowledge and
expertise critical to treating patients with the Waismann Method sm of
Neuro-Regulation. He is a Diplomat of the American Board of Pain Medicine.
Positions
Co-Director, Waismann Method sm
Multi-disciplinary chronic pain
management, Newport Beach Pain Institute
Vice Chairman, Department of
Anesthesiology, Orange
Coast Memorial
Medical Center
Director, Acute Pain Management
Services, OCMMC
Chairman, Physician Well-Being
Committee, OCMMC
Experience
1996 - 2000
Medical Director, Coast Pain
Management
1992-1996
Vice Chairman, Department of
Anesthesiology
Director, Acute and Chronic Pain
Medicine Service
FHP, Inc.
Fountain Valley, California
1983-1984
Associate Director, California Diabetes Control Program
San Bernardino, California
Education
2009 American
Board of Addiction Medicine Diplomate
1989-1992
Residency
Loma Linda
University Medical
Center
Loma Linda, California
Anesthesiology Residency
1988-1989
Internship
Santa Clara Valley
Medical Center
San Jose, California
Transitional Internship
For more information, including details on the
2010 ABAM Certification Examination, please visit www.ABAM.net
Get Help with Opiates Addiction Now
Call us today to discuss how the Waismann Method can free you from your Opioids dependency and get your life back.
-
Call (310) 205-0808 or (888) 987-HOPE (4673) during business
hours. for more information about rapid detox
treatment for prescription drug addiction
After-hours
and weekends, please call (310) 927-7155. -
send
us a confidential email.
- Actiq detox
- Buprenorphine detox
- Codeine detox
- Darvocet detox
- Demerol detox
- Dilaudid detox
- Duragesic detox
- Fentanyl detox
- Heroin detox
- Hydrocodone detox
- LAAM detox
- Lorcet detox
- Lortab detox
- Methadone detox
- Morphine detox
- MS Contin detox
- Norco detox
- Opiate detox
- Oxycodone detox
- OxyContin detox
- Percocet detox
- Percodan detox
- Stadol detox
- Suboxone detox
- Tramadol detox
- Ultram detox
- Vicodin detox
- Xodol detox
- Zydone detox
